SCK CEN And Quirem Medical Start Producing Ho-166 Microspheres At BR2 Reactor SCK CEN and Quirem Medical announce the first production of holmium-166 microspheres for patient use at the BR2 reactor in Mol, Belgium. A first clinical QuiremSpheres® patient procedure took place with radioactive holmium-166 microspheres, an innovative product for treating liver cancer patients. QuiremSpheres is…
How radiation can save lives Associazione Italiana Nucleare interviewed Dr. Riccardo Bevilacqua, an Italian nuclear physicist who dedicates himself, his work and passion to radiological safety and protection, so showing how radiation can have several positive purposes and, above all, can save lives. The interview has been translated into English by ENS. Associazione Italiana Nucleare…
SCK CEN And IBA Cooperate To Enable The Production Of Actinium-225 SCK CEN – Belgian Nuclear Research Center (ENS Corporate Member) and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announced a strategic R&D partnership to enable the production of Actinium-225 (225Ac), a novel radioisotope which has significant potential in…
HFR 60th Anniversary And The Rising Demand For Radiopharmaceuticals The demand for medical treatments is rising sharply, partly due to the increased incidence of cancer. In the past year, 115,000 new cases of cancer have been diagnosed in the Netherlands, 13,000 of which prostate cancer. Consequently, NRG|PALLAS is seeing an increase in the demand for…
Westinghouse and EDF To Collaborate To Produce Cobalt-60 Radioisotope During the last World Nuclear Exhibition, Westinghouse Electric Company and EDF (both ENS Corporate Members) signed a Memorandum of Understanding to produce Cobalt-60 radioisotope in select Pressurized Water Reactors (PWR) owned and operated by EDF in France. Cobalt-60 plays a critical role in the safety of medical…
Framatome and Exelon Signed A MoU To Strengthen Cobalt-60 Production Framatome (ENS Corporate Member) and Exelon Generation recently announced the signature of a Memorandum of Understanding to develop solutions to produce Cobalt-60 in Pressurized Water Reactors (PWR) operated by Exelon Generation in the US. Cobalt-60 is a radioisotope produced in nuclear reactors out of natural…
The World’s First Lutetium-177 Produced At Commercial Nuclear Reactor The Canadian nuclear operator Bruce Power announced the world’s first production of lutetium-177 (Lu-177) at a commercial nuclear reactor, its Bruce-7 nuclear power plant in Ontario. This milestone has been achieved thanks to the international cooperation between Bruce Power, Isogen (a Kinectrics and Framatome company), and…
Ensuring The Future – Outlook on Medical Radioisotopes and Uranium Supply Chains in Europe Interview with Euratom Supply Agency Director General Agnieszka Kazmierczak Medical radioisotopes are a crucial tool in beating cancer and other diseases, offering several and innovative solutions in terms of diagnostics and treatments. Despite this key role, the whole production and supply…
The New PSI Pharmaceutical Laboratory Is Ready For Production Paul Scherrer Institut (PSI, ENS Corporate Member) announced that its new pharmaceutical laboratory for the manufacture of radiopharmaceuticals is ready for production, accordingly to the operating licence granted by the Swiss Agency for Therapeutic Products (Swissmedic). For more than 20 years, in collaboration with ETH Zurich,…
Framatome Announces New Investment Supporting Nuclear Medicine Framatome (ENS Corporate Member) announced that it acquired a minority stake in the French startup Global Morpho Pharma. With this investment, Framatome strengthens its activities serving nuclear medicine development and expands its support for the supply chain of Lutetium-177 and other promising isotopes for therapeutic applications. Global Morpho…